Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

Stock Information for Serina Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Serina Therapeutics Inc.

Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42
Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan
Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.